Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GM.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.129 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAY.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.8.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.5.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.1.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.34EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.15.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.9.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FA.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
ER.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.1.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CQ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FS.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.54EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
N.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.1.15 (Gamma)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.348EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.575EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Q.4 (Alpha)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.442EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.1.1 (Gamma)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.2.5.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.600EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.1.12 (Gamma)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.525 (Eta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.6 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.5.5 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.1.7 (Gamma)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.24 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.45 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.70 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.26.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.5 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.108 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.32 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.46.3 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used